Pharma & Healthcare
Global Functional Dyspepsia Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 25, 25
- ID: 335350
- Pages: 160
- Figures: 149
- Views: 4
In 2024, the global market size of Functional Dyspepsia Drug was estimated to be worth US$ 6284 million and is forecast to reach approximately US$ 7603 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.
The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Segment by Application
Hospitals
Drugstores
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Functional Dyspepsia Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Functional Dyspepsia Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.
The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Segment by Application
Hospitals
Drugstores
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Functional Dyspepsia Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Functional Dyspepsia Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Functional Dyspepsia Drug Product Introduction
1.2 Market by Type
1.2.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts
2.1.1 Global Functional Dyspepsia Drug Revenue 2020-2031
2.1.2 Global Functional Dyspepsia Drug Sales 2020-2031
2.2 Functional Dyspepsia Drug Market Size by Region: 2024 Versus 2031
2.3 Functional Dyspepsia Drug Sales by Region (2020-2031)
2.3.1 Global Functional Dyspepsia Drug Sales by Region: 2020-2025
2.3.2 Global Functional Dyspepsia Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Functional Dyspepsia Drug Sales Market Share by Region (2020-2031)
2.4 Functional Dyspepsia Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Functional Dyspepsia Drug Revenue by Region: 2020-2025
2.4.2 Global Functional Dyspepsia Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Functional Dyspepsia Drug Sales by Type (2020-2031)
3.1.1.1 Global Functional Dyspepsia Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Functional Dyspepsia Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Functional Dyspepsia Drug Revenue by Type (2020-2031)
3.1.2.1 Global Functional Dyspepsia Drug Revenue by Type (2020-2031)
3.1.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2020-2031)
3.1.3 Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Functional Dyspepsia Drug Sales by Application (2020-2031)
3.2.1.1 Global Functional Dyspepsia Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Functional Dyspepsia Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Functional Dyspepsia Drug Revenue by Application (2020-2031)
3.2.2.1 Global Functional Dyspepsia Drug Revenue by Application (2020-2031)
3.2.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2020-2031)
3.2.3 Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prokinetic Drugs of Functional Dyspepsia Drug Revenue Market Share by Application
3.3.2 Gastric Antisecretory Drugs of Functional Dyspepsia Drug Revenue Market Share by Application
3.3.3 Others of Functional Dyspepsia Drug Revenue Market Share by Application
4 Global Functional Dyspepsia Drug by Manufacturers
4.1 Global Top Functional Dyspepsia Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Functional Dyspepsia Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Functional Dyspepsia Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Functional Dyspepsia Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Functional Dyspepsia Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Functional Dyspepsia Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Functional Dyspepsia Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Functional Dyspepsia Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Functional Dyspepsia Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Functional Dyspepsia Drug Manufacturing Base Distribution, Product Type
4.5.1 Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
4.5.3 Manufacturers Functional Dyspepsia Drug Product Type and Application
4.5.4 Prokinetic Drugs Market Sales of Functional Dyspepsia Drug by Manufacturer
4.5.5 Gastric Antisecretory Drugs Market Sales of Functional Dyspepsia Drug by Manufacturer
4.5.6 Others Market Sales of Functional Dyspepsia Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bayer
5.1.1 Bayer Company Information
5.1.2 Bayer Description, Business Overview
5.1.3 Bayer Functional Dyspepsia Drug Products Offered
5.1.4 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Bayer Functional Dyspepsia Drug Sales by Product in 2024
5.1.6 Bayer Functional Dyspepsia Drug Sales by Application in 2024
5.1.7 Bayer Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.1.8 Bayer Recent Developments
5.2 Sumitomo
5.2.1 Sumitomo Company Information
5.2.2 Sumitomo Description, Business Overview
5.2.3 Sumitomo Functional Dyspepsia Drug Products Offered
5.2.4 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sumitomo Functional Dyspepsia Drug Sales by Product in 2024
5.2.6 Sumitomo Functional Dyspepsia Drug Sales by Application in 2024
5.2.7 Sumitomo Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.2.8 Sumitomo Recent Developments
5.3 Cadila Pharmaceuticals
5.3.1 Cadila Pharmaceuticals Company Information
5.3.2 Cadila Pharmaceuticals Description, Business Overview
5.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Products Offered
5.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Product in 2024
5.3.6 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Application in 2024
5.3.7 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.3.8 Cadila Pharmaceuticals Recent Developments
5.4 Teva
5.4.1 Teva Company Information
5.4.2 Teva Description, Business Overview
5.4.3 Teva Functional Dyspepsia Drug Products Offered
5.4.4 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teva Functional Dyspepsia Drug Sales by Product in 2024
5.4.6 Teva Functional Dyspepsia Drug Sales by Application in 2024
5.4.7 Teva Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.4.8 Teva Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Company Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Functional Dyspepsia Drug Products Offered
5.5.4 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Functional Dyspepsia Drug Sales by Product in 2024
5.5.6 Johnson & Johnson Functional Dyspepsia Drug Sales by Application in 2024
5.5.7 Johnson & Johnson Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Company Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Functional Dyspepsia Drug Products Offered
5.6.4 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Functional Dyspepsia Drug Sales by Product in 2024
5.6.6 Pfizer Functional Dyspepsia Drug Sales by Application in 2024
5.6.7 Pfizer Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Sanofi
5.7.1 Sanofi Company Information
5.7.2 Sanofi Description, Business Overview
5.7.3 Sanofi Functional Dyspepsia Drug Products Offered
5.7.4 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Sanofi Functional Dyspepsia Drug Sales by Product in 2024
5.7.6 Sanofi Functional Dyspepsia Drug Sales by Application in 2024
5.7.7 Sanofi Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.7.8 Sanofi Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Company Information
5.8.2 AstraZeneca Description, Business Overview
5.8.3 AstraZeneca Functional Dyspepsia Drug Products Offered
5.8.4 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 AstraZeneca Functional Dyspepsia Drug Sales by Product in 2024
5.8.6 AstraZeneca Functional Dyspepsia Drug Sales by Application in 2024
5.8.7 AstraZeneca Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.8.8 AstraZeneca Recent Developments
5.9 Jiangsu Aosaikang Pharma
5.9.1 Jiangsu Aosaikang Pharma Company Information
5.9.2 Jiangsu Aosaikang Pharma Description, Business Overview
5.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Products Offered
5.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Product in 2024
5.9.6 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Application in 2024
5.9.7 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.9.8 Jiangsu Aosaikang Pharma Recent Developments
5.10 Eisai
5.10.1 Eisai Company Information
5.10.2 Eisai Description, Business Overview
5.10.3 Eisai Functional Dyspepsia Drug Products Offered
5.10.4 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Eisai Functional Dyspepsia Drug Sales by Product in 2024
5.10.6 Eisai Functional Dyspepsia Drug Sales by Application in 2024
5.10.7 Eisai Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.10.8 Eisai Recent Developments
5.11 Kyowa Kirin Pharmaceuticals
5.11.1 Kyowa Kirin Pharmaceuticals Company Information
5.11.2 Kyowa Kirin Pharmaceuticals Description, Business Overview
5.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Products Offered
5.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Product in 2024
5.11.6 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Application in 2024
5.11.7 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.11.8 Kyowa Kirin Pharmaceuticals Recent Developments
5.12 Hanmi Pharm
5.12.1 Hanmi Pharm Company Information
5.12.2 Hanmi Pharm Description, Business Overview
5.12.3 Hanmi Pharm Functional Dyspepsia Drug Products Offered
5.12.4 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Hanmi Pharm Functional Dyspepsia Drug Sales by Product in 2024
5.12.6 Hanmi Pharm Functional Dyspepsia Drug Sales by Application in 2024
5.12.7 Hanmi Pharm Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.12.8 Hanmi Pharm Recent Developments
6 North America
6.1 North America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
6.2 North America Functional Dyspepsia Drug Market Facts & Figures by Country
6.2.1 North America Functional Dyspepsia Drug Sales by Country (2020-2031)
6.2.2 North America Functional Dyspepsia Drug Revenue by Country (2020-2031)
6.3 North America Functional Dyspepsia Drug Sales by Type (2020-2025)
6.4 North America Functional Dyspepsia Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Functional Dyspepsia Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Functional Dyspepsia Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Functional Dyspepsia Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Functional Dyspepsia Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
8.2 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
8.2.1 Europe Functional Dyspepsia Drug Sales by Country (2020-2031)
8.2.2 Europe Functional Dyspepsia Drug Revenue by Country (2020-2031)
8.3 Europe Functional Dyspepsia Drug Sales by Type (2020-2025)
8.4 Europe Functional Dyspepsia Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
9.2 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
9.2.1 Latin America Functional Dyspepsia Drug Sales by Country (2020-2031)
9.2.2 Latin America Functional Dyspepsia Drug Revenue by Country (2020-2031)
9.3 Latin America Functional Dyspepsia Drug Sales by Type (2020-2025)
9.4 Latin America Functional Dyspepsia Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Functional Dyspepsia Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Functional Dyspepsia Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Functional Dyspepsia Drug Supply Chain Analysis
11.2 Functional Dyspepsia Drug Key Raw Materials and Upstream Suppliers
11.3 Functional Dyspepsia Drug Clients Analysis
11.4 Functional Dyspepsia Drug Sales Channel and Sales Model Analysis
11.4.1 Functional Dyspepsia Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Functional Dyspepsia Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Functional Dyspepsia Drug Distributors
12 Functional Dyspepsia Drug Market Dynamics
12.1 Functional Dyspepsia Drug Industry Trends
12.2 Functional Dyspepsia Drug Market Drivers
12.3 Functional Dyspepsia Drug Market Challenges
12.4 Functional Dyspepsia Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Functional Dyspepsia Drug Product Introduction
1.2 Market by Type
1.2.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts
2.1.1 Global Functional Dyspepsia Drug Revenue 2020-2031
2.1.2 Global Functional Dyspepsia Drug Sales 2020-2031
2.2 Functional Dyspepsia Drug Market Size by Region: 2024 Versus 2031
2.3 Functional Dyspepsia Drug Sales by Region (2020-2031)
2.3.1 Global Functional Dyspepsia Drug Sales by Region: 2020-2025
2.3.2 Global Functional Dyspepsia Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Functional Dyspepsia Drug Sales Market Share by Region (2020-2031)
2.4 Functional Dyspepsia Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Functional Dyspepsia Drug Revenue by Region: 2020-2025
2.4.2 Global Functional Dyspepsia Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Functional Dyspepsia Drug Sales by Type (2020-2031)
3.1.1.1 Global Functional Dyspepsia Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Functional Dyspepsia Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Functional Dyspepsia Drug Revenue by Type (2020-2031)
3.1.2.1 Global Functional Dyspepsia Drug Revenue by Type (2020-2031)
3.1.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2020-2031)
3.1.3 Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Functional Dyspepsia Drug Sales by Application (2020-2031)
3.2.1.1 Global Functional Dyspepsia Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Functional Dyspepsia Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Functional Dyspepsia Drug Revenue by Application (2020-2031)
3.2.2.1 Global Functional Dyspepsia Drug Revenue by Application (2020-2031)
3.2.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2020-2031)
3.2.3 Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prokinetic Drugs of Functional Dyspepsia Drug Revenue Market Share by Application
3.3.2 Gastric Antisecretory Drugs of Functional Dyspepsia Drug Revenue Market Share by Application
3.3.3 Others of Functional Dyspepsia Drug Revenue Market Share by Application
4 Global Functional Dyspepsia Drug by Manufacturers
4.1 Global Top Functional Dyspepsia Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Functional Dyspepsia Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Functional Dyspepsia Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Functional Dyspepsia Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Functional Dyspepsia Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Functional Dyspepsia Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Functional Dyspepsia Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Functional Dyspepsia Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Functional Dyspepsia Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Functional Dyspepsia Drug Manufacturing Base Distribution, Product Type
4.5.1 Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
4.5.3 Manufacturers Functional Dyspepsia Drug Product Type and Application
4.5.4 Prokinetic Drugs Market Sales of Functional Dyspepsia Drug by Manufacturer
4.5.5 Gastric Antisecretory Drugs Market Sales of Functional Dyspepsia Drug by Manufacturer
4.5.6 Others Market Sales of Functional Dyspepsia Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bayer
5.1.1 Bayer Company Information
5.1.2 Bayer Description, Business Overview
5.1.3 Bayer Functional Dyspepsia Drug Products Offered
5.1.4 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Bayer Functional Dyspepsia Drug Sales by Product in 2024
5.1.6 Bayer Functional Dyspepsia Drug Sales by Application in 2024
5.1.7 Bayer Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.1.8 Bayer Recent Developments
5.2 Sumitomo
5.2.1 Sumitomo Company Information
5.2.2 Sumitomo Description, Business Overview
5.2.3 Sumitomo Functional Dyspepsia Drug Products Offered
5.2.4 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sumitomo Functional Dyspepsia Drug Sales by Product in 2024
5.2.6 Sumitomo Functional Dyspepsia Drug Sales by Application in 2024
5.2.7 Sumitomo Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.2.8 Sumitomo Recent Developments
5.3 Cadila Pharmaceuticals
5.3.1 Cadila Pharmaceuticals Company Information
5.3.2 Cadila Pharmaceuticals Description, Business Overview
5.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Products Offered
5.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Product in 2024
5.3.6 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Application in 2024
5.3.7 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.3.8 Cadila Pharmaceuticals Recent Developments
5.4 Teva
5.4.1 Teva Company Information
5.4.2 Teva Description, Business Overview
5.4.3 Teva Functional Dyspepsia Drug Products Offered
5.4.4 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teva Functional Dyspepsia Drug Sales by Product in 2024
5.4.6 Teva Functional Dyspepsia Drug Sales by Application in 2024
5.4.7 Teva Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.4.8 Teva Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Company Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Functional Dyspepsia Drug Products Offered
5.5.4 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Functional Dyspepsia Drug Sales by Product in 2024
5.5.6 Johnson & Johnson Functional Dyspepsia Drug Sales by Application in 2024
5.5.7 Johnson & Johnson Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Company Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Functional Dyspepsia Drug Products Offered
5.6.4 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Functional Dyspepsia Drug Sales by Product in 2024
5.6.6 Pfizer Functional Dyspepsia Drug Sales by Application in 2024
5.6.7 Pfizer Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Sanofi
5.7.1 Sanofi Company Information
5.7.2 Sanofi Description, Business Overview
5.7.3 Sanofi Functional Dyspepsia Drug Products Offered
5.7.4 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Sanofi Functional Dyspepsia Drug Sales by Product in 2024
5.7.6 Sanofi Functional Dyspepsia Drug Sales by Application in 2024
5.7.7 Sanofi Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.7.8 Sanofi Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Company Information
5.8.2 AstraZeneca Description, Business Overview
5.8.3 AstraZeneca Functional Dyspepsia Drug Products Offered
5.8.4 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 AstraZeneca Functional Dyspepsia Drug Sales by Product in 2024
5.8.6 AstraZeneca Functional Dyspepsia Drug Sales by Application in 2024
5.8.7 AstraZeneca Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.8.8 AstraZeneca Recent Developments
5.9 Jiangsu Aosaikang Pharma
5.9.1 Jiangsu Aosaikang Pharma Company Information
5.9.2 Jiangsu Aosaikang Pharma Description, Business Overview
5.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Products Offered
5.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Product in 2024
5.9.6 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Application in 2024
5.9.7 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.9.8 Jiangsu Aosaikang Pharma Recent Developments
5.10 Eisai
5.10.1 Eisai Company Information
5.10.2 Eisai Description, Business Overview
5.10.3 Eisai Functional Dyspepsia Drug Products Offered
5.10.4 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Eisai Functional Dyspepsia Drug Sales by Product in 2024
5.10.6 Eisai Functional Dyspepsia Drug Sales by Application in 2024
5.10.7 Eisai Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.10.8 Eisai Recent Developments
5.11 Kyowa Kirin Pharmaceuticals
5.11.1 Kyowa Kirin Pharmaceuticals Company Information
5.11.2 Kyowa Kirin Pharmaceuticals Description, Business Overview
5.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Products Offered
5.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Product in 2024
5.11.6 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Application in 2024
5.11.7 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.11.8 Kyowa Kirin Pharmaceuticals Recent Developments
5.12 Hanmi Pharm
5.12.1 Hanmi Pharm Company Information
5.12.2 Hanmi Pharm Description, Business Overview
5.12.3 Hanmi Pharm Functional Dyspepsia Drug Products Offered
5.12.4 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Hanmi Pharm Functional Dyspepsia Drug Sales by Product in 2024
5.12.6 Hanmi Pharm Functional Dyspepsia Drug Sales by Application in 2024
5.12.7 Hanmi Pharm Functional Dyspepsia Drug Sales by Geographic Area in 2024
5.12.8 Hanmi Pharm Recent Developments
6 North America
6.1 North America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
6.2 North America Functional Dyspepsia Drug Market Facts & Figures by Country
6.2.1 North America Functional Dyspepsia Drug Sales by Country (2020-2031)
6.2.2 North America Functional Dyspepsia Drug Revenue by Country (2020-2031)
6.3 North America Functional Dyspepsia Drug Sales by Type (2020-2025)
6.4 North America Functional Dyspepsia Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Functional Dyspepsia Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Functional Dyspepsia Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Functional Dyspepsia Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Functional Dyspepsia Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
8.2 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
8.2.1 Europe Functional Dyspepsia Drug Sales by Country (2020-2031)
8.2.2 Europe Functional Dyspepsia Drug Revenue by Country (2020-2031)
8.3 Europe Functional Dyspepsia Drug Sales by Type (2020-2025)
8.4 Europe Functional Dyspepsia Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
9.2 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
9.2.1 Latin America Functional Dyspepsia Drug Sales by Country (2020-2031)
9.2.2 Latin America Functional Dyspepsia Drug Revenue by Country (2020-2031)
9.3 Latin America Functional Dyspepsia Drug Sales by Type (2020-2025)
9.4 Latin America Functional Dyspepsia Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Functional Dyspepsia Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Functional Dyspepsia Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Functional Dyspepsia Drug Supply Chain Analysis
11.2 Functional Dyspepsia Drug Key Raw Materials and Upstream Suppliers
11.3 Functional Dyspepsia Drug Clients Analysis
11.4 Functional Dyspepsia Drug Sales Channel and Sales Model Analysis
11.4.1 Functional Dyspepsia Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Functional Dyspepsia Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Functional Dyspepsia Drug Distributors
12 Functional Dyspepsia Drug Market Dynamics
12.1 Functional Dyspepsia Drug Industry Trends
12.2 Functional Dyspepsia Drug Market Drivers
12.3 Functional Dyspepsia Drug Market Challenges
12.4 Functional Dyspepsia Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Functional Dyspepsia Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Functional Dyspepsia Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 5. Global Functional Dyspepsia Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Functional Dyspepsia Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Functional Dyspepsia Drug Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Functional Dyspepsia Drug Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Functional Dyspepsia Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Functional Dyspepsia Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Functional Dyspepsia Drug Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Functional Dyspepsia Drug Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Functional Dyspepsia Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Functional Dyspepsia Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Functional Dyspepsia Drug Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Functional Dyspepsia Drug Sales Share by Manufacturer (2020-2025)
Table 18. Functional Dyspepsia Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Functional Dyspepsia Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Functional Dyspepsia Drug Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Functional Dyspepsia Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2024)
Table 24. Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
Table 26. Manufacturers Functional Dyspepsia Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Bayer Company Information
Table 29. Bayer Description and Business Overview
Table 30. Bayer Functional Dyspepsia Drug Product
Table 31. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Bayer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 33. Bayer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 34. Bayer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 35. Bayer Recent Developments
Table 36. Sumitomo Company Information
Table 37. Sumitomo Description and Business Overview
Table 38. Sumitomo Functional Dyspepsia Drug Product
Table 39. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 41. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 42. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 43. Sumitomo Recent Developments
Table 44. Cadila Pharmaceuticals Company Information
Table 45. Cadila Pharmaceuticals Description and Business Overview
Table 46. Cadila Pharmaceuticals Functional Dyspepsia Drug Product
Table 47. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 49. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 50. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 51. Cadila Pharmaceuticals Recent Developments
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Functional Dyspepsia Drug Product
Table 55. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Teva Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 57. Teva Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 58. Teva Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 59. Teva Recent Developments
Table 60. Johnson & Johnson Company Information
Table 61. Johnson & Johnson Description and Business Overview
Table 62. Johnson & Johnson Functional Dyspepsia Drug Product
Table 63. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 65. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 66. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 67. Johnson & Johnson Recent Developments
Table 68. Pfizer Company Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Functional Dyspepsia Drug Product
Table 71. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 73. Pfizer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 74. Pfizer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 75. Pfizer Recent Developments
Table 76. Sanofi Company Information
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Functional Dyspepsia Drug Product
Table 79. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 81. Sanofi Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 82. Sanofi Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 83. Sanofi Recent Developments
Table 84. AstraZeneca Company Information
Table 85. AstraZeneca Description and Business Overview
Table 86. AstraZeneca Functional Dyspepsia Drug Product
Table 87. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 89. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 90. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 91. AstraZeneca Recent Developments
Table 92. Jiangsu Aosaikang Pharma Company Information
Table 93. Jiangsu Aosaikang Pharma Description and Business Overview
Table 94. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product
Table 95. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 97. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 98. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 99. Jiangsu Aosaikang Pharma Recent Developments
Table 100. Eisai Company Information
Table 101. Eisai Description and Business Overview
Table 102. Eisai Functional Dyspepsia Drug Product
Table 103. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Eisai Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 105. Eisai Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 106. Eisai Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 107. Eisai Recent Developments
Table 108. Kyowa Kirin Pharmaceuticals Company Information
Table 109. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 110. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product
Table 111. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 113. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 114. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 115. Kyowa Kirin Pharmaceuticals Recent Developments
Table 116. Hanmi Pharm Company Information
Table 117. Hanmi Pharm Description and Business Overview
Table 118. Hanmi Pharm Functional Dyspepsia Drug Product
Table 119. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 121. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 122. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 123. Hanmi Pharm Recent Developments
Table 124. North America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 125. North America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 126. North America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 129. North America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 130. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 131. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2026-2031) & (M Units)
Table 132. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 135. Asia-Pacific Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 136. Europe Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 137. Europe Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 138. Europe Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 141. Europe Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 142. Latin America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 143. Latin America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 144. Latin America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 147. Latin America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 148. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 153. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 154. Functional Dyspepsia Drug Key Raw Materials, Industry Status and Trend
Table 155. Functional Dyspepsia Drug Key Raw Materials and Upstream Suppliers
Table 156. Functional Dyspepsia Drug Clients Status and Trend
Table 157. Functional Dyspepsia Drug Typical Clients
Table 158. Functional Dyspepsia Drug Distributors
Table 159. Functional Dyspepsia Drug Market Trends
Table 160. Functional Dyspepsia Drug Market Drivers
Table 161. Functional Dyspepsia Drug Market Challenges
Table 162. Functional Dyspepsia Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Functional Dyspepsia Drug Product Picture
Figure 2. Global Functional Dyspepsia Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Functional Dyspepsia Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Prokinetic Drugs Product Picture
Figure 5. Gastric Antisecretory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Functional Dyspepsia Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Functional Dyspepsia Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Functional Dyspepsia Drug Report Years Considered
Figure 12. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Functional Dyspepsia Drug Market Size 2020-2031 (US$ Million)
Figure 14. Global Functional Dyspepsia Drug Sales 2020-2031 (M Units)
Figure 15. Global Functional Dyspepsia Drug Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 17. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Prokinetic Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 24. Gastric Antisecretory Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Functional Dyspepsia Drug Sales Share by Manufacturer in 2024
Figure 27. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Prokinetic Drugs Market Sales Proportion by Manufacturer in 2024
Figure 29. Gastric Antisecretory Drugs Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 32. North America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 33. North America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 39. Europe Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 41. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 42. Europe Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 43. Europe Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 44. Latin America Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 48. Latin America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 54. Functional Dyspepsia Drug Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Functional Dyspepsia Drug Raw Materials by Region in 2024
Figure 56. Functional Dyspepsia Drug Distribution Channels
Figure 57. Global Functional Dyspepsia Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Functional Dyspepsia Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Functional Dyspepsia Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Functional Dyspepsia Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 5. Global Functional Dyspepsia Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Functional Dyspepsia Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Functional Dyspepsia Drug Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Functional Dyspepsia Drug Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Functional Dyspepsia Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Functional Dyspepsia Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Functional Dyspepsia Drug Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Functional Dyspepsia Drug Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Functional Dyspepsia Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Functional Dyspepsia Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Functional Dyspepsia Drug Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Functional Dyspepsia Drug Sales Share by Manufacturer (2020-2025)
Table 18. Functional Dyspepsia Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Functional Dyspepsia Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Functional Dyspepsia Drug Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Functional Dyspepsia Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2024)
Table 24. Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
Table 26. Manufacturers Functional Dyspepsia Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Bayer Company Information
Table 29. Bayer Description and Business Overview
Table 30. Bayer Functional Dyspepsia Drug Product
Table 31. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Bayer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 33. Bayer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 34. Bayer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 35. Bayer Recent Developments
Table 36. Sumitomo Company Information
Table 37. Sumitomo Description and Business Overview
Table 38. Sumitomo Functional Dyspepsia Drug Product
Table 39. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 41. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 42. Sumitomo Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 43. Sumitomo Recent Developments
Table 44. Cadila Pharmaceuticals Company Information
Table 45. Cadila Pharmaceuticals Description and Business Overview
Table 46. Cadila Pharmaceuticals Functional Dyspepsia Drug Product
Table 47. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 49. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 50. Cadila Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 51. Cadila Pharmaceuticals Recent Developments
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Functional Dyspepsia Drug Product
Table 55. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Teva Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 57. Teva Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 58. Teva Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 59. Teva Recent Developments
Table 60. Johnson & Johnson Company Information
Table 61. Johnson & Johnson Description and Business Overview
Table 62. Johnson & Johnson Functional Dyspepsia Drug Product
Table 63. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 65. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 66. Johnson & Johnson Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 67. Johnson & Johnson Recent Developments
Table 68. Pfizer Company Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Functional Dyspepsia Drug Product
Table 71. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 73. Pfizer Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 74. Pfizer Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 75. Pfizer Recent Developments
Table 76. Sanofi Company Information
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Functional Dyspepsia Drug Product
Table 79. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 81. Sanofi Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 82. Sanofi Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 83. Sanofi Recent Developments
Table 84. AstraZeneca Company Information
Table 85. AstraZeneca Description and Business Overview
Table 86. AstraZeneca Functional Dyspepsia Drug Product
Table 87. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 89. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 90. AstraZeneca Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 91. AstraZeneca Recent Developments
Table 92. Jiangsu Aosaikang Pharma Company Information
Table 93. Jiangsu Aosaikang Pharma Description and Business Overview
Table 94. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product
Table 95. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 97. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 98. Jiangsu Aosaikang Pharma Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 99. Jiangsu Aosaikang Pharma Recent Developments
Table 100. Eisai Company Information
Table 101. Eisai Description and Business Overview
Table 102. Eisai Functional Dyspepsia Drug Product
Table 103. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Eisai Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 105. Eisai Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 106. Eisai Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 107. Eisai Recent Developments
Table 108. Kyowa Kirin Pharmaceuticals Company Information
Table 109. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 110. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product
Table 111. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 113. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 114. Kyowa Kirin Pharmaceuticals Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 115. Kyowa Kirin Pharmaceuticals Recent Developments
Table 116. Hanmi Pharm Company Information
Table 117. Hanmi Pharm Description and Business Overview
Table 118. Hanmi Pharm Functional Dyspepsia Drug Product
Table 119. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Product in 2024
Table 121. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Application in 2024
Table 122. Hanmi Pharm Sales Proportion of Functional Dyspepsia Drug by Geographic Area in 2024
Table 123. Hanmi Pharm Recent Developments
Table 124. North America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 125. North America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 126. North America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 129. North America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 130. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2020-2025) & (M Units)
Table 131. Asia-Pacific Functional Dyspepsia Drug Sales by Region (2026-2031) & (M Units)
Table 132. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Functional Dyspepsia Drug Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 135. Asia-Pacific Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 136. Europe Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 137. Europe Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 138. Europe Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 141. Europe Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 142. Latin America Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 143. Latin America Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 144. Latin America Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 147. Latin America Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 148. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2020-2025) & (M Units)
Table 153. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2020-2025) & (M Units)
Table 154. Functional Dyspepsia Drug Key Raw Materials, Industry Status and Trend
Table 155. Functional Dyspepsia Drug Key Raw Materials and Upstream Suppliers
Table 156. Functional Dyspepsia Drug Clients Status and Trend
Table 157. Functional Dyspepsia Drug Typical Clients
Table 158. Functional Dyspepsia Drug Distributors
Table 159. Functional Dyspepsia Drug Market Trends
Table 160. Functional Dyspepsia Drug Market Drivers
Table 161. Functional Dyspepsia Drug Market Challenges
Table 162. Functional Dyspepsia Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Functional Dyspepsia Drug Product Picture
Figure 2. Global Functional Dyspepsia Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Functional Dyspepsia Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Prokinetic Drugs Product Picture
Figure 5. Gastric Antisecretory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Functional Dyspepsia Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Functional Dyspepsia Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Functional Dyspepsia Drug Report Years Considered
Figure 12. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Functional Dyspepsia Drug Market Size 2020-2031 (US$ Million)
Figure 14. Global Functional Dyspepsia Drug Sales 2020-2031 (M Units)
Figure 15. Global Functional Dyspepsia Drug Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 17. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Prokinetic Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 24. Gastric Antisecretory Drugs of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Functional Dyspepsia Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Functional Dyspepsia Drug Sales Share by Manufacturer in 2024
Figure 27. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Prokinetic Drugs Market Sales Proportion by Manufacturer in 2024
Figure 29. Gastric Antisecretory Drugs Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 32. North America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 33. North America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Functional Dyspepsia Drug Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 39. Europe Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 41. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 42. Europe Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 43. Europe Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 44. Latin America Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 48. Latin America Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Functional Dyspepsia Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Application (2020-2025)
Figure 54. Functional Dyspepsia Drug Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Functional Dyspepsia Drug Raw Materials by Region in 2024
Figure 56. Functional Dyspepsia Drug Distribution Channels
Figure 57. Global Functional Dyspepsia Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Functional Dyspepsia Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232